Wytwarzanie produktów leczniczych jest dla nas nie tylko kwestia wykonania pewnego procesu technologicznego, ale misją związaną z człowiekiem opartą na wysokim standardzie jakości, bezpieczeństwa i skuteczności leków.
Mamy aktywną i kluczową rolę w podnoszeniu standardów życia codziennego. Sprawiamy, że społeczeństwo jest lepiej poinformowane, zdrowsze, szczęśliwsze i bezpieczniejsze
Sofia, Bulgaria, June 25, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 24, 2020 the Company sold 5 000 own shares representing 0.0037% of the share capital of the Company, at a total value of BGN 15 750 on the Bulgarian Stock Exchange, the average price per share was 3.1500 BGN.
The total number of treasury shares after this transaction is 9 053 467, representing 6.716% of the share capital of the Company.
Sofia, Bulgaria, June 23, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 22, 2020 the Company sold 25 000 own shares representing 0.0185% of the share capital of the Company, at a total value of BGN 78 750 on the Bulgarian Stock Exchange, the average price per share was 3.1500 BGN.
The total number of treasury shares after this transaction is 9 058 467, representing 6.720% of the share capital of the Company.
Sofia, Bulgaria, June 22, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 19, 2020 the Company sold 6 000 own shares representing 0.0045% of the share capital of the Company, at a total value of BGN 18 870 on the Bulgarian Stock Exchange, the average price per share was 3.1450 BGN.
The total number of treasury shares after this transaction is 9 083 467, representing 6.739% of the share capital of the Company.